Many actions of adenosine are those of a rescue autacoid whose main function is to protect tissues from ischemia. To study these processes in humans we propose to evoke local adenosine mechanisms in the forearm skeletal muscle by increased metabolic demands during restriction of blood flow (sustained isometric exercise). Ischemic exercise, but not ischemia alone, induces systemic sympathetic activation (the """"""""exercise pressor reflex"""""""") due in part to release of metabolites that activate muscle afferents. We hypothesize that adenosine is a metabolic trigger of this reflex. In agreement with this hypothesis, injection of adenosine into the brachial artery triggers sympathetic stimulation that mimics muscle afferent activation. This effect is localized to the forearm and is not explained by pain or local vasodilation. Conversely, the blockade of forearm adenosine receptors with intrabrachial theophylline blunts the exercise pressor reflex Finally, we have recently found that interstitial levels of adenosine are increased during ischemic exercise of the forearm, but not during ischemia alone, which agrees with the observation that ischemia alone is not a sufficient stimulus to trigger muscle afferent activation. We propose to further test this hypothesis by modulating interstitial adenosine levels with graded ischemic exercise, and by potentiating or blocking endogenous adenosine mechanisms. Adenosine-induced sympathetic activation seems at odds with its postulated role as a protective autacoid against ischemia. It is possible, however, that local adenosine exerts a compensatory inhibition of norepinephrine release, with the potential of restraining sympathetically-mediated vasoconstriction. We propose to test the hypothesis that, under physiological conditions, local adenosine inhibits the release of norepinephrine evoked by local ischemia or by reflex sympathetic activation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL056693-03
Application #
6202534
Study Section
Project Start
1999-08-01
Project End
2000-07-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Mar, Philip L; Raj, Satish R (2018) Orthostatic hypotension for the cardiologist. Curr Opin Cardiol 33:66-72
Chaugai, Sandip; Dickson, Alyson L; Shuey, Megan M et al. (2018) Co-Prescription of Strong CYP1A2 Inhibitors and the Risk of Tizanidine-Associated Hypotension: A Retrospective Cohort Study. Clin Pharmacol Ther :
van den Berg, Maarten P; Almomani, Rowida; Biaggioni, Italo et al. (2018) Mutations in CYB561 Causing a Novel Orthostatic Hypotension Syndrome. Circ Res 122:846-854
Mai, Tu H; Garland, Emily M; Diedrich, André et al. (2017) Hepatic and renal mechanisms underlying the osmopressor response. Auton Neurosci 203:58-66
Kawai, V K; Levinson, R T; Adefurin, A et al. (2017) A genetic risk score that includes common type 2 diabetes risk variants is associated with gestational diabetes. Clin Endocrinol (Oxf) 87:149-155
Pezawas, Thomas; Diedrich, André; Robertson, David et al. (2017) Risk of arrhythmic death in ischemic heart disease: a prospective, controlled, observer-blind risk stratification over 10 years. Eur J Clin Invest 47:231-240
Adefurin, A; Ghimire, L V; Kohli, U et al. (2017) Genetic variation in the alpha1B-adrenergic receptor and vascular response. Pharmacogenomics J 17:366-371
Kaufman, Melissa R; Chang-Kit, Laura; Raj, Satish R et al. (2017) Overactive bladder and autonomic dysfunction: Lower urinary tract symptoms in females with postural tachycardia syndrome. Neurourol Urodyn 36:610-613
Shaw, Brett H; Garland, Emily M; Black, Bonnie K et al. (2017) Optimal diagnostic thresholds for diagnosis of orthostatic hypotension with a 'sit-to-stand test'. J Hypertens 35:1019-1025
Kawai, Vivian K; Levinson, Rebecca T; Adefurin, Abiodun et al. (2017) Variation in the ?2A-adrenergic receptor gene and risk of gestational diabetes. Pharmacogenomics 18:1381-1386

Showing the most recent 10 out of 315 publications